Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2024-03-31
Balance Sheet
Cash & Cash Equivalents	:	2,724
Curr. Assets	:	98,237
Fixed Assets	:	40,497
Total Assets	:	138,734
Curr. Liabilities	:	34,183
Long Term Debt	:	4,866
Minority Interest	:	0
Total Liabilities	:	39,049
Paid-Up Capital	:	2,000
Total Equity	:	99,685
Income Statement
Total Sales	:	182,674
Gross Profit	:	11,689
Operating Profit	:	5,459
Net Income	:	4,369
Cash Flow Statement
Cash From Operating Act	:	-12,266
Cash From Investing Act	:	-78
Cash From Financing Act	:	7,404
Per Share Data (in IDR)
EPS	:	2.18
Book Value	:	49.84
Financial Ratios
Der	:	0.39
Roa	:	0.10
Roe	:	0.18
Npm	:	0.02
Opm	:	0.03
Growth Year to Year
Sales (%)	:	100.00%
Net Income (%)	:	100.00%
Total Assets (%) (%)	:	100.00%
Total Liabilities (%)	:	100.00%

1	RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion

2	Illumina and PREMIA partner to expand clinical access to CGP in Asia

3	Rokid and Ant International Announce Integration of Smart Glasses Payment Capability

4	Salcomp's Debut on CES 2026

5	Call for Application for 2026 Tsinghua Amgen Scholars Program

RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion